ABEONA THERAPEUTICS INC.: Rubric Capital Management LP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Rubric Capital Management LP disclosed a stake exceeding 5% in Abeona Therapeutics Inc. via a Schedule 13G filing with the SEC (accession 0001104659-26-128285). The exact share count and percentage were not specified in the filing headline. The disclosure signals a new or increased position by the activist-oriented investor in the gene therapy developer. Investors will watch for further filings or correspondence indicating whether Rubric intends to push for strategic or governance changes.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Abeona Therapeutics Inc., Rubric Capital Management LP